Search results (1320)
« Back to PublicationsThe clinical and molecular significance associated with STING signaling in breast cancer.
Parkes EE. et al, (2021), NPJ Breast Cancer, 7
A Phase Ib Open-Label, Dose-Escalation Study of NUC-1031 in Combination with Carboplatin for Recurrent Ovarian Cancer.
Kazmi F. et al, (2021), Clin Cancer Res, 27, 3028 - 3038
A qualitative exploration of the barriers to and facilitators of clozapine monitoring in a secure psychiatric setting.
Blagden S. et al, (2021), BJPsych Bull, 45, 134 - 140
Camidanlumab tesirine in patients with relapsed or refractory lymphoma: a phase 1, open-label, multicentre, dose-escalation, dose-expansion study.
Hamadani M. et al, (2021), Lancet Haematol, 8, e433 - e445
Development of Immunotherapy Combination Strategies in Cancer.
Yap TA. et al, (2021), Cancer Discov, 11, 1368 - 1397
Brentuximab vedotin with chemotherapy in adolescents and young adults (AYAs) with stage III or IV Hodgkin lymphoma: A subgroup analysis from the phase 3 Echelon-1 study.
Crosswell HE. et al, (2021), JOURNAL OF CLINICAL ONCOLOGY, 39
Longitudinal and individual symptom analyses of momelotinib and ruxolitinib treated myelofibrosis patients from SIMPLIFY-1.
Mesa RA. et al, (2021), JOURNAL OF CLINICAL ONCOLOGY, 39
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
Ahern DJ. et al, (2021)
Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor initiating cells
Masuda K. et al, (2021), JCI Insight
Checkpoint-blocker-induced autoimmunity is associated with favourable outcome in metastatic melanoma and distinct T-cell expression profiles.
Ye W. et al, (2021), Br J Cancer, 124, 1661 - 1669
Metastasis and Immune Evasion from Extracellular cGAMP Hydrolysis.
Li J. et al, (2021), Cancer Discov, 11, 1212 - 1227
Infection-related morbidity and mortality among older patients with DLBCL treated with full- or attenuated-dose R-CHOP.
Eyre TA. et al, (2021), Blood Adv, 5, 2229 - 2236
NICE public health guidance update.
Blagden S. et al, (2021), J Public Health (Oxf), 43, e107 - e109
Activated Regulatory T-Cells, Dysfunctional and Senescent T-Cells Hinder the Immunity in Pancreatic Cancer
SIVAKUMAR S. et al, (2021), Molecular Biomarkers and Precision Medicine for Pancreatic, Liver and Biliary Tract Cancers
Application of Single-Cell Approaches to Study Myeloproliferative Neoplasm Biology.
Royston D. et al, (2021), Hematol Oncol Clin North Am, 35, 279 - 293
Burkitt Lymphoma International Prognostic Index.
Olszewski AJ. et al, (2021), J Clin Oncol, 39, 1129 - 1138